GlassScriptPhysician profile
James Ghattas
NPI 1730537572
$17,369.97
in general payments reported to CMS, 2019-2025
11 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2021: $11K · 2022: $2,509 · 2023: $3,880 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,830 · Consulting Fee: $1,050 · Food and Beverage: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,829.85 |
| Consulting Fee | $1,050.00 |
| Food and Beverage | $178.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $10,361.75 | 2021-2022 | |
| Pajunk Medical Systems, LP | $3,879.85 | 2023 | E-Cath Plus Acc. Tsui |
| Abbott Laboratories | $1,368.35 | 2019-2022 | |
| Boston Scientific Corporation | $407.80 | 2021-2025 | General - Pain Management |
| Stryker Corporation | $378.60 | 2022 | |
| Csl Behring | $339.90 | 2019-2022 | |
| Painteq LLC | $227.98 | 2021-2022 | |
| Abbvie INC. | $144.04 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.87 | 2022 | |
| Mml US, INC. | $118.24 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.59 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ghattas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.